Back to Journals » Therapeutics and Clinical Risk Management

Therapeutics and Clinical Risk Management

ISSN: 1178-203X


Editor-in-Chief: Professor Garry Walsh

ISSN 1176-6336 (Print) - went to online only in 2009

An international, peer-reviewed open access journal of clinical therapeutics and risk management, focusing on concise rapid reporting of clinical studies in all therapeutic areas, outcomes, safety, and programs for the effective, safe, and sustained use of medicines, therapeutic and surgical interventions in all clinical areas.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Latest articles:

- 5 records -

Safety and Efficacy of Liver Venous Deprivation Following Transarterial Chemoembolization Before Major Hepatectomy for Hepatocellular Carcinoma

Sy TV, Dung LT, Giang BV, Nghia NQ, Viet Khai N, Manh Thau C, Gia Anh P, Hong Son T, Minh Duc N

Therapeutics and Clinical Risk Management 2023, 19:425-433

Published Date: 18 May 2023

Clinical Utility of Deucravacitinib for the Management of Moderate to Severe Plaque Psoriasis

Jin JQ, Spencer RK, Reddy V, Bhutani T, Liao W

Therapeutics and Clinical Risk Management 2023, 19:413-423

Published Date: 18 May 2023

Effect of Tricalcium Phosphate on Healing of Non-Unions: An Observational Study of over 400 Non-Unions

Ferbert T, Münch C, Findeisen S, Pauly W, Miska M, Grossner T, Tanner MC, Schmidmaier G, Helbig L

Therapeutics and Clinical Risk Management 2023, 19:395-404

Published Date: 12 May 2023


Read more articles